HomeCompareRADLY vs JNJ

RADLY vs JNJ: Dividend Comparison 2026

RADLY yields 1.77% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RADLY wins by $37.92M in total portfolio value
10 years
RADLY
RADLY
● Live price
1.77%
Share price
$4.61
Annual div
$0.08
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.94M
Annual income
$34,216,279.84
Full RADLY calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — RADLY vs JNJ

📍 RADLY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRADLYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RADLY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RADLY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RADLY
Annual income on $10K today (after 15% tax)
$150.11/yr
After 10yr DRIP, annual income (after tax)
$29,083,837.86/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, RADLY beats the other by $29,083,134.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RADLY + JNJ for your $10,000?

RADLY: 50%JNJ: 50%
100% JNJ50/50100% RADLY
Portfolio after 10yr
$18.98M
Annual income
$17,108,553.81/yr
Blended yield
90.14%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RADLY
No analyst data
Altman Z
3.7
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RADLY buys
0
JNJ buys
0
No recent congressional trades found for RADLY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRADLYJNJ
Forward yield1.77%3.36%
Annual dividend / share$0.08$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR100%5.8%
Portfolio after 10y$37.94M$20.0K
Annual income after 10y$34,216,279.84$827.78
Total dividends collected$37.63M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RADLY vs JNJ ($10,000, DRIP)

YearRADLY PortfolioRADLY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,053$353.19$10,676$355.77+$377.00RADLY
2$12,557$729.70$11,407$389.39+$1.1KRADLY
3$14,985$1,549.45$12,198$426.53+$2.8KRADLY
4$19,490$3,456.27$13,056$467.62+$6.4KRADLY
5$29,257$8,402.59$13,987$513.12+$15.3KRADLY
6$54,881$23,576.23$14,998$563.56+$39.9KRADLY
7$141,387$82,663.44$16,098$619.52+$125.3KRADLY
8$549,338$398,054.63$17,295$681.69+$532.0KRADLY
9$3,478,610$2,890,817.64$18,599$750.82+$3.46MRADLY
10$37,938,392$34,216,279.84$20,022$827.78+$37.92MRADLY

RADLY vs JNJ: Complete Analysis 2026

RADLYStock

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. As of March 31, 2022, the company operated a network of 2,530 drug stores in 26 Brazilian states. It also markets its goods through telesales and its three call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.

Full RADLY Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this RADLY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RADLY vs SCHDRADLY vs JEPIRADLY vs ORADLY vs KORADLY vs MAINRADLY vs ABBVRADLY vs MRKRADLY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.